NECTIN2 and neoplasm: The anti-Nectin-2 mAb Y-443, representing epitope bins VII, showed in vivo anti-tumor effects on OV-90 and MDA-MB-231 cells (Figure 9 and 10), and all the experimental results suggested that ADCC is the main mechanism of action of Y-443.